Merck Spokesperson Tells Benzinga FDA Postponed PDUFA Date On sBLA For Keytruda In Mediastinal B-Cell Lymphoma To July 3rd After Co. Submitted Add'l Data; PDUFA Decision Was Originally Scheduled For April 3rd